A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

May 5, 2017

Study Completion Date

May 5, 2017

Conditions
Psoriasis
Interventions
DRUG

GSK2981278 ointment

"GSK2981278 ointment will be applied topically twice daily for 8 weeks to all subjects in Part A and to randomized subjects in Part B. GSK2981278 will be a white to off-white ointment and a thin layer will be applied to all affected areas for given timeframe.~GSK2981278 is available as white to off-white ointment in unit strength 4% (w/w), 2% (w/w) and 0.8% (w/w), for topical application for application as thin layer to all affected areas ."

DRUG

Vehicle ointment

It will be supplied as white to off-white vehicle ointment for topical application.

Trial Locations (1)

20095

GSK Investigational Site, Hamburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03004846 - A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis | Biotech Hunter | Biotech Hunter